Search


Current filters:

Clear current filters  or Add more filters

View Option



Results 1-10 of 96 (Search time: 0.119 seconds).

  Leptospirosis is Associated with Markedly Increased Triglycerides and Small Dense Low-Density Lipoprotein and Decreased High-Density Lipoprotein (Journal article)

  Native valve endocarditis due to Micrococcus luteus: a case report and review of the literature (Journal article)

  Combining Rosuvastatin with Sartans of Different Peroxisome Proliferator-Activated Receptor-gamma Activating Capacity Is Not Associated with Different Changes in Low-Density Lipoprotein Subfractions and Plasma Lipoprotein-Associated Phospholipase A(2) (Journal article)

  Study rationale and design of OPTIMISE, a randomised controlled trial on the effect of benchmarking on quality of care in type 2 diabetes mellitus (Journal article)

  THE EFFECTS OF COMBINING ROSUVASTATIN WITH SARTANS OF DIFFERENT PPAR gamma ACTIVATING CAPACITY ON LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A(2) (Journal article)

  The Effects of Hypolipidemic Regimen on Low Density Lipoprotein (Ldl) Phenotype in Patients with Mixed Hyperlipidemia (Journal article)

  Effect of Ezetimibe on Markers of Oxidative Stress in Patients with Hypercholesterolemia (Journal article)

  Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia (Journal article)

  Plasma Visfatin Concentration Is a Marker of an Atherogenic Metabolic Profile (Journal article)

  The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia (Journal article)